风疹疫苗免疫策略研讨
吴红宇,王克安,金水高
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 吴红宇,王克安,金水高
参考文献(References)：
- 1 耿贯一.流行病学(第二卷).第2版,北京:人民卫生出版社,1996,541
- 2 F T Cutts, et al. Control of rubella and congenital rubella syndrome (CRS) in developing counntries, part 1: burden of disease from CRS. Bulletin of the World Health Organization, 1997,75(1):55～68
- 3 Robertson CM et al. Serological evaluation of a measles, mumps, and rubella vaccine. Archives of disease in child hood,1988,63:612～616
- 4 Schoub BD et al. Measles, mumps and rubella immunization at nine months in a developing country. Pediatric infectious disease journal,1990, 9:263～267
- 5 O’Shea S et al.Persistence of rubella antibody 8-18years after vaccination. British medical journal, 1984,288: 1043
- 6 Best JM. Rubella vaccines: past, presentand future. Epidemiology and infection, 1991, 107: 17～30
- 7 Rubella prevention: recommendations of the Immunization Practices Advisory Committee(ACIP). Morbidity and mortality weekly report,1990, 39(RR-15):1～18
- 8 S. E. Robertson, et al. Control of rubella and congnital rubella syndrome (CRS) in developing countries,part 2: vaccination against rubella. Bulletin of the World Health Organization,1997,75(1):69～80
- 9 The sex and age distribution of the world populations, the 1994 revision. New York, United Nations, 1994
- 10 Global Programme for Vaccines and Immunization: progrm report 1994. Unpublished document WHO/GPV/95.1, 1995 (available upon request from Global Programme for Vaccines and Immunization, World Health Organization, 1211 Geneva 27, Switzerland)11 Plotkin S A Rubella vaccine.In: Plotkin S A, Mortier E A, eds. Vaccines,2nd edition. London, W. B. Saunders, 1994
- 12 De Qqadris C A Measles elimination in the Americas: evolving strategies. JAMA, 1996, 275(3): 224～229